Dr. Varunsiri Atti, MD

Dr. Atti practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Atti's NPI, 1336660984, was assigned on July 5, 2017. Dr. Atti graduated from Sri Venkatesvara Medical College NTR in 2015. Dr. Atti holds Texas license U3466.

Dr. Atti's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Atti's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Atti is also affiliated with Medical Center Hospital. The medical group on file is MCH ProCare. Dmand AI also links Dr. Atti to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atti practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Atti's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Atti is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Atti's licenses on file in 3 states: Texas, West Virginia and Michigan.

CMS data shows 1,229 Medicare services from Dr. Atti across 15 procedure codes in 2024, for 549 Medicare patients. Medicare paid $33,840 for them.

CMS counts 549 Medicare patients who saw Dr. Atti in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atti's median patient age at 59, with 53% women.

In 2024, Dr. Atti wrote 405 Medicare Part D claims for 146 patients. 91% of them were for generic drugs. CMS names the drug for 299 of them, across 12 drugs with 11 or more claims each, at $2,403 in total drug cost. In 2023, CMS named 271 claims across 12 drugs.

Dr. Atti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Atti, more than 33% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Dr. Atti, published from 2017 to 2023. 2019 was the busiest year, with 14. The most frequent topics are Patient Readmission, Percutaneous Coronary Intervention and Postoperative Complications. Dr. Atti has published most often in Am J Cardiol. Dr. Atti's most frequent co-authors are Varun Kumar, Mohit K. Turagam, MD and Dhanunjaya Reddy Lakkireddy, MD.

CMS Open Payments shows 144 general payments to Dr. Atti from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 67% of the total. Abiomed paid the most, $2,571.

Dmand AI lists 3 awards for Dr. Atti, most recently Alpha Omega Alpha, Gamma Chapter in 2019.

Dr. Atti graduated from Sri Venkatesvara Medical College NTR in 2015.

Dr. Atti is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.